ResMed Inc (NYSE:RMD) reports a robust 11% increase in net revenue year-over-year. Significant growth in Sleep and Breathing Health segment, showcasing an 11% rise in sales. Strong gross margin ...

ResMed is taking a “smart devices” and Big Data approach to further entrench itself as one of the two leading players in the global obstructive sleep apnea, or OSA, market. With cloud ...

Residential Care Software Revenue: Increased by 12%. ResMed Inc (NYSE:RMD) reported a strong quarter with an 11% revenue growth, driven by demand for sleep health and breathing health medical devices.

For the three months ended 30 September, ResMed reported an 11% increase in revenue to US$1,224.5 million. This was largely in line with consensus estimates for the period. Management advised that ...

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at https://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD ...

Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 24, 2024 (GLOBE NEWSWIRE ...

I’ve been testing the 32-inch Samsung ViewFinity S8 (S80UD) for the last month. Here’s what you should know about the budget-friendly monitor, including all the ways it’s impressed me.

ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...

Lyanne Harrison’s rating is based on a combination of strong performance indicators and optimistic forecasts for Resmed. The company’s revenue and non-GAAP net profit after tax (NPAT ...

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing ...